Carl Zeiss boosts digital solutions with cloud-based cataract surgery planning tool

Carl Zeiss added Veracity Innovations' cloud-based tool for cataract surgical planning, management and analysis to its digital solutions stable.

Carl Zeiss Meditec announced its acquisition of Veracity Innovations and its cloud-based platform that provides physicians with quick and easy access to clinical data at each stage of patient care.

The Veracity platform debuted at the American Society of Cataract and Refractive Surgery’s annual meeting. It connects with electronic medical records and diagnostic devices to supply doctors with “the most relevant and critical data” that they need at each step of treatment, from the initial consultation through the planning, scheduling, procedural and postoperative process, according to a statement.

The technology aims to make this process more efficient, while also cutting down on human error, Zeiss said in the statement.


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

RELATED: Philips, to create clinical, cloud-based platform

"Digital technology is fundamentally changing our world and has a major impact in healthcare," said CEO Ludwin Monz. "Efficiently bringing together relevant information and making smart use of data in a secure way, along with artificial intelligence, is reshaping how medicine is practiced today and is opening up new realms of possibility for advancing patient care."

Zeiss already offers a number of digital solutions for eye doctors, such as tools for decision support and data management, said Jim Mazzo, global president of ophthalmic devices at Zeiss.

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.